168 related articles for article (PubMed ID: 29149768)
1. Mitochondrial DNA changes in pedunculopontine cholinergic neurons in Parkinson disease.
Bury AG; Pyle A; Elson JL; Greaves L; Morris CM; Hudson G; Pienaar IS
Ann Neurol; 2017 Dec; 82(6):1016-1021. PubMed ID: 29149768
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial abnormality associates with type-specific neuronal loss and cell morphology changes in the pedunculopontine nucleus in Parkinson disease.
Pienaar IS; Elson JL; Racca C; Nelson G; Turnbull DM; Morris CM
Am J Pathol; 2013 Dec; 183(6):1826-1840. PubMed ID: 24099985
[TBL] [Abstract][Full Text] [Related]
3. Pedunculopontine cell loss and protein aggregation direct microglia activation in parkinsonian rats.
Elson JL; Yates A; Pienaar IS
Brain Struct Funct; 2016 May; 221(4):2319-41. PubMed ID: 25989851
[TBL] [Abstract][Full Text] [Related]
4. A non-cholinergic neuronal loss in the pedunculopontine nucleus of toxin-evoked parkinsonian rats.
Pienaar IS; van de Berg W
Exp Neurol; 2013 Oct; 248():213-23. PubMed ID: 23769975
[TBL] [Abstract][Full Text] [Related]
5. Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease.
Bensaid M; Michel PP; Clark SD; Hirsch EC; François C
Exp Neurol; 2016 Jan; 275 Pt 1():209-19. PubMed ID: 26571193
[TBL] [Abstract][Full Text] [Related]
6. Temporal-Spatial Profiling of Pedunculopontine Galanin-Cholinergic Neurons in the Lactacystin Rat Model of Parkinson's Disease.
Elson JL; Kochaj R; Reynolds R; Pienaar IS
Neurotox Res; 2018 Jul; 34(1):16-31. PubMed ID: 29218504
[TBL] [Abstract][Full Text] [Related]
7. An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease.
Pienaar IS; Harrison IF; Elson JL; Bury A; Woll P; Simon AK; Dexter DT
Brain Struct Funct; 2015 Jan; 220(1):479-500. PubMed ID: 24292256
[TBL] [Abstract][Full Text] [Related]
8. Neuromelanin, neurotransmitter status and brainstem location determine the differential vulnerability of catecholaminergic neurons to mitochondrial DNA deletions.
Elstner M; Müller SK; Leidolt L; Laub C; Krieg L; Schlaudraff F; Liss B; Morris C; Turnbull DM; Masliah E; Prokisch H; Klopstock T; Bender A
Mol Brain; 2011 Dec; 4():43. PubMed ID: 22188897
[TBL] [Abstract][Full Text] [Related]
9. DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian Rats.
Sharma PK; Wells L; Rizzo G; Elson JL; Passchier J; Rabiner EA; Gunn RN; Dexter DT; Pienaar IS
Neurotherapeutics; 2020 Jul; 17(3):1120-1141. PubMed ID: 31965550
[TBL] [Abstract][Full Text] [Related]
10. Nurr1, Pitx3, and α7 nAChRs mRNA Expression in Nigral Tissue of Rats with Pedunculopontine Neurotoxic Lesion.
Blanco-Lezcano L; Alberti-Amador E; González-Fraguela ME; Larrea GZ; Pérez-Serrano RM; Jiménez-Luna NA; Serrano-Sánchez T; Francis-Turner L; Camejo-Rodriguez D; Vega-Hurtado Y
Medicina (Kaunas); 2019 Sep; 55(10):. PubMed ID: 31547185
[No Abstract] [Full Text] [Related]
11. Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson's disease.
Pienaar IS; Gartside SE; Sharma P; De Paola V; Gretenkord S; Withers D; Elson JL; Dexter DT
Mol Neurodegener; 2015 Sep; 10():47. PubMed ID: 26394842
[TBL] [Abstract][Full Text] [Related]
12. Pedunculopontine Nucleus Cholinergic Deficiency in Cervical Dystonia.
Mente K; Edwards NA; Urbano D; Ray-Chaudhury A; Iacono D; Alho ATDL; Alho EJL; Amaro E; Horovitz SG; Hallett M
Mov Disord; 2018 May; 33(5):827-834. PubMed ID: 29508906
[TBL] [Abstract][Full Text] [Related]
13. Pedunculopontine cholinergic cell loss in hallucinating Parkinson disease patients but not in dementia with Lewy bodies patients.
Hepp DH; Ruiter AM; Galis Y; Voorn P; Rozemuller AJ; Berendse HW; Foncke EM; van de Berg WD
J Neuropathol Exp Neurol; 2013 Dec; 72(12):1162-70. PubMed ID: 24226265
[TBL] [Abstract][Full Text] [Related]
14. The pedunclopontine nucleus and Parkinson's disease.
Tubert C; Galtieri D; Surmeier DJ
Neurobiol Dis; 2019 Aug; 128():3-8. PubMed ID: 30171892
[TBL] [Abstract][Full Text] [Related]
15. Selective cholinergic depletion of pedunculopontine tegmental nucleus aggravates freezing of gait in parkinsonian rats.
Xiao H; Li M; Cai J; Li N; Zhou M; Wen P; Xie Z; Wang Q; Chang J; Zhang W
Neurosci Lett; 2017 Oct; 659():92-98. PubMed ID: 28803956
[TBL] [Abstract][Full Text] [Related]
16. Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson disease.
Weathers SP; Kotagal V; Bohnen NI; Chou KL
Parkinsonism Relat Disord; 2014 Jan; 20(1):13-6. PubMed ID: 24070538
[TBL] [Abstract][Full Text] [Related]
17. Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease.
Müller ML; Albin RL; Kotagal V; Koeppe RA; Scott PJ; Frey KA; Bohnen NI
Brain; 2013 Nov; 136(Pt 11):3282-9. PubMed ID: 24056537
[TBL] [Abstract][Full Text] [Related]
18. Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease.
Dölle C; Flønes I; Nido GS; Miletic H; Osuagwu N; Kristoffersen S; Lilleng PK; Larsen JP; Tysnes OB; Haugarvoll K; Bindoff LA; Tzoulis C
Nat Commun; 2016 Nov; 7():13548. PubMed ID: 27874000
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial DNA deletions/rearrangements in parkinson disease and related neurodegenerative disorders.
Gu G; Reyes PE; Golden GT; Woltjer RL; Hulette C; Montine TJ; Zhang J
J Neuropathol Exp Neurol; 2002 Jul; 61(7):634-9. PubMed ID: 12125742
[TBL] [Abstract][Full Text] [Related]
20. Thalamic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders.
Kotagal V; Müller ML; Kaufer DI; Koeppe RA; Bohnen NI
Neurosci Lett; 2012 Apr; 514(2):169-72. PubMed ID: 22414859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]